A pilot study of thalidomide for patients with symptomatic mesenteric panniculitis

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 12, 2002, Pages 2115-2122

  Ginsburg, P M ^a   Ehrenpreis, E D ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; THALIDOMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEG EDEMA; MALE; MESENTERY DISEASE; PANNICULITIS; PARESTHESIA; PERIPHERAL NEUROPATHY; PILOT STUDY; PRIORITY JOURNAL; RASH; REMISSION; SEDATION; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PANNICULITIS, PERITONEAL; PILOT PROJECTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THALIDOMIDE; TREATMENT OUTCOME;

EID: 0036909156     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01383.x     Document Type: Article

References (26)

1. Emory TS, Monihan JM, Carr NJ, Sobin LH. Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: A single entity? Am J Surg Pathol 1997; 21(4): 392-8.
2. Ginsburg PM, Ehrenpreis ED. Mesenteric panniculitis. In: The NORD Guide to Rare Diseases. Philadelphia: Lippincott Williams & Wilkins, 2002.
3. Bala A, Coderre SP, Johnson DR, Nayak V. Treatment of sclerosing mesenteritis with corticosteroids and azathioprine. Can J Gastroenterol 2001; 15(8): 533-5.
4. Tytgat GN, Roozendaal K, Winter W, Esseveld MR. Successful treatment of a patient with retractile mesenteritis with prednisone and azathioprine. Gastroenterology 1980; 79(2): 352-6.
5. Bush RW, Hammar SP Jr, Rudolph RH. Sclerosing mesenteritis. Response to cyclophosphamide. Arch Intern Med 1986; 146(3): 503-5.
6. Genereau T, Bellin MF, Wechsler B, et al. Demonstration of efficacy of combining corticosteroids and colchicine in two patients with idiopathic sclerosing mesenteritis. Dig Dis Sci 1996; 41(4): 684-8.
7. Venkataramani A, Behling CA, Lyche KD. Sclerosing mesenteritis: An unusual cause of abdominal pain in an HIV-positive patient. Am J Gastroenterol 1997; 92(6): 1059-60.
8. Mazure R, Fernandez Marty P, Niveloni S, et al. Successful treatment of retractile mesenteritis with oral progesterone. Gastroenterology 1998; 114(6): 1313-7.
9. Cuff R, Landercasper J, Schlack S. Sclerosing mesenteritis. Surgery 2001; 129(4): 509-10.
10. Durst AL, Freund H, Rosenmann E, Birnbaum D. Mesenteric panniculitis: Review of the literature and presentation of cases. Surgery 1977; 81(2): 203-11.
11. Ginsburg PM, Dassopoulos T, Ehrenpreis ED. Thalidomide treatment for refractory Crohn's disease: A review of the history, pharmacological mechanisms and clinical literature. Ann Med 2001; 33(8): 516-25.
12. Ehrenpreis ED, Kane SV, Cohen LB, Cohen RD, Hanauer SB. Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial. Gastroenterology 1999; 117(6): 1271-7.
13. Vasiliauskas EA, Kam LY, Abreu-Martin MT, et al. An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease. Gastroenterology 1999; 117(6): 1278-87.
14. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia; a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol 1999; 94(9): 2390-7.
15. Jura V. Sulla mesenterite retrattile e sclerosante. Policlinico 1924; 31: 575-81.
16. Sabate JM, Torrubia S, Maideu J, Franquet T, Monill JM, Perez C. Sclerosing mesenteritis: Imaging findings in 17 patients. Am J Roentgenol 1999; 172(3): 625-9.
17. Papadaki HA, Kouroumalis EA, Stefanaki K, et al. Retractile mesenteritis presenting as fever of unknown origin and autoimmune haemolytic anaemia. Digestion 2000; 61(2): 145-8.
18. Hemaidan A, Vanegas F, Alvarez OA, Arroyo MA, Lee M. Mesenteric lipodystrophy with fever of unknown origin and mesenteric calcifications. South Med J 1999; 92(5): 513-6.
19. Sans M, Varas M, Anglada A, Esperanza Bachs M, Navarro S, Brugues J. Mesenteric panniculitis presenting as fever of unknown origin. Am J Gastroenterol 1995; 90(7): 1159-61.
20. Kipfer RE, Moertel CG, Dahlin DC. Mesenteric lipodystrophy. Ann Intern Med 1974; 80(5): 582-8.
21. Kikiros CS, Edis AJ. Mesenteric panniculitis resulting in bowel obstruction: Response to steroids. Aust N Z J Surg 1989; 59(3): 287-90.
22. Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991; 173(3): 699-703.
23. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993; 177(6): 1675-80.
24. Bauditz J, Wedel S, Lochs H. Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease. Gut 2002; 50(2): 196-200.
25. Keifer JA, Guttridge DC, Ashburner BP, Baldwin AS Jr. Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity. J Biol Chem 2001; 276(25): 22 382-7.
26. Rowland TL, McHugh SM, Deighton J, Ewan PW, Dearman RJ, Kimber I. Differential effect of thalidomide and dexamethasone on the transcription factor NF-kappa B. Int Immunopharmacol 2001; 1(1): 49-61.